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Introduction: Gait disorders in cervical dystonia (CD) are reported in patients under DBS or in severe
cases complicated with spinal deformities.
Objective: to assess walking motor pattern in CD patients without DBS and not presenting scoliosis.
Methods: Computerized gait analysis (CGA) was performed in CD patients, before and after botulinum
toxin (BoNT) injections, and in healthy controls (HC). Spatiotemporal (ST) parameters were compared
between CD and HC groups. Correlation analysis was conducted between ST parameters and clinical
features of CD patients.
Results: CD patients demonstrated a signiﬁcant reduction of velocity, stride length, % of swing phase, and
dynamic stability index while stride and swing time were increased. No signiﬁcant effect of BoNT was
detected. A signiﬁcant inverse correlation was found between TWSTRS and stride length.
Conclusion: CD patients may have a slow gait with subclinical evidence. Our data suggest this alteration
might be an endophenotipic feature of CD.
© 2017 Published by Elsevier Ltd.1. Introduction
Cervical dystonia (CD) is one of the most frequent forms of focal
dystonia predominantly presenting with a combination of tilting
and rotation of the head [1]. Severe CD can be complicated by spinal
deformities, such as scoliosis, that can afterwards impair walking
[2]. Presently there are few studies addressing gait pattern in CD.
Previous computerized gait analysis (CGA) studies in dystonia have
only described gait abnormalities occurring in patients with focal
forms (including CD) under pallidal deep brain stimulation (DBS)
[3]. The mechanism of gait abnormalities triggered by DBS in these
patients is unknown, and hypothesized to be due to the spreading
of electricity towards the cortico-spinal tract or by an ‘anti-kinetic’
effect of stimulation itself, as described in PD patients [4]. A
description of gait pattern in CD patients without DBS and with noersity of Toronto, Movement
urst St, 7 Mc412, Toronto, ON
no).
sito, et al., Cervical dystonia
.parkreldis.2017.07.005clinical evidence of spinal deformities could therefore be of inter-
est. The aim of the present study is to objectively assess the gait
pattern e particularly the spatiotemporal (ST) parameters e of
these patients. Although CD patients do not clinically display a
walking impairment, our approach may identify subclinical gait
abnormalities representing a speciﬁc feature of this movement
disorder. Furthermore, as the gait of CD patients might be impaired
by abnormal head posture, we explored whether successful treat-
ment with botulinum toxin (BoNT) may result in gait changes.2. Patients and methods
Consecutive patients with isolated idiopathic CD followed in our
BoNT clinic were enrolled. All participants gave written informed
consent prior to their inclusion. Patients with clinical evidence of
spinal deformities, pyramidal signs or other conditions potentially
impairing gait were excluded. All patients have been evaluated
with Adam's forward bend test in order to exclude thoracic and
lumbar curves [5] and only patients with a Cobb angle measuring
less than 20 were included. Clinical data collected included diseasepatients display subclinical gait changes, Parkinsonism and Related
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measured with the severity subscale of the Toronto Western
Spasmodic Torticollis Rating scale (TWSTRS) [6]. The walking of 13
CD patients was analyzed by an opto-kinetic 3D gait analysis (BST
GAITLAB, BST SMART DX 6 TVC, Milan, Italy) at least three months
after the last treatment with BoNT (CD group). Eight patients un-
derwent a repeated CGA 4weeks after the last treatment with BoNT
to control for possible changes of gait related to the correction of
head deviation following injections (CDpost group). The same as-
sessments were performed in 19 healthy subjects as control group
(HC group) and 12 of them underwent a repeated assessment
during which they were asked to walk with the head rotated 45 (6
towards the right side and 6 towards the left) (HCht group). All
groups were matched for age and sex.
Parameters of gait were detected using the Davis protocol [7].
The recorded temporal parameters were: stance time, double
support time, stride time and cadence. The following spatial pa-
rameters were analyzed: stride length, step width, step length, step
asymmetry (deﬁned as the ratio between right and left step length)
and velocity. The dynamic stability index, calculated as the ratio
between single and double support time, was also calculated. Co-
efﬁcient of variation (CV) was calculated for swing phase, stride
length and time.
2.1. Statistical analysis
Descriptive statistics were computed using IBM SPSS Statistics
(version 22 for Windows). Group matching regarding age and
gender was tested by unpaired t-test and c2 respectively. As
assessed by the Shapiro-Wilk test all data did not meet the
assumption for normality apart from TWSTRS score. Accordingly,
the Mann-Whitney U test was used to compare CD with HC and
HCht. Within group comparisons (CD vs. CDpost and HC vs. HCht)
were performed using a Wilcoxon paired test. In order to minimize
the possibility of a type 1 error, we set statistical signiﬁcance at
p < 0.0167 after Bonferroni correction for multiple comparisons. A
nonparametric correlation analysis (Spearman rank test) was used
to correlate instrumented gait measures with disease duration,
whereas a parametric correlation (Pearson test) was adopted to
correlate TWSTRS score (normally distributed) with gait variables,
which were log transformed. In the correlation analysis, we took
into account only the gait parameters that were signiﬁcantly
different between CD patients and HC after correction for multiple
comparisons.
3. Results
3.1. Demographic and clinical data
This study included 13 patients with idiopathic CD presenting
the following phenotypes: 4 torticollis, 7 laterocollis and 2 retro-
collis. Details of Demographic and clinical data are reported in
Table 1.
3.2. Computerized gait analysis
Since right versus left values were not signiﬁcantly different for
all ST parameters within each group, we analyzed the averaged
value. In comparison with both HC and HCht, CD patients were
found to have a signiﬁcantly reduced velocity, stride length, % of
swing phase, and dynamic stability index; the CV of stride and
swing times of CD patients were signiﬁcantly increased compared
to HC; ﬁnally, cadence and step length was reduced in CD patients
only when compared to HCht (Fig. 1, Table 1). The remaining pa-
rameters assessed did not differ signiﬁcantly across groupsPlease cite this article in press as: M. Esposito, et al., Cervical dystonia
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differences between HC and HCht and between CD and CDpost
despite clinical improvement indicated by a signiﬁcant TWSTRS
score reduction 4 weeks after the treatment with BoNT (Supple-
mental material online e Tables 1 and 2).
3.3. Correlation analysis
A signiﬁcant inverse correlation was found between the
TWSTRS score and stride length (r ¼ 0.703; p ¼ 0.044 correction
for multiple comparison). No other signiﬁcant correlations were
detected (Supplemental material online e Table 3).
4. Discussion
This study demonstrates that patients with idiopathic and iso-
lated CD have subtle and subclinical gait abnormalities including
increased variability and lower velocity. We believe that such ab-
normalities are associatedwith the neuronal dysfunction leading to
dystonia and do not merely reﬂect the detrimental result of head
deviation, e.g. due to abnormal posture or its inﬂuence on the
vestibular system. In fact, posture changes after BoNT did not alter
gait parameters in CD patients and no detrimental effect of forced
head deviation was detected in HC. Furthermore, we found a sig-
niﬁcant inverse correlation between dystonia severity and stride
length.
Several hypotheses can be formulated to explain our ﬁndings.
Although isolated idiopathic CD is a disorder that affects only the
neck muscles with possible spread to the face and less frequently
the upper limb [8], a subtle concomitant lower limb involvement
cannot be ruled out. In addition, patients with a long history of CD
may develop spinal deformities with severe scoliosis producing gait
difﬁculties, as already reported [9]. However, patients in this study
did not present clinical evidence of spinal deformities nor pyra-
midal signs possibly indicating a subclinical myelopathy. We
excluded patients with lumbar and thoracic curves measuring
more than 20 as a previous study demonstrated that subjects with
mild scoliosis (Cobb angle <20) only present slight step length and
stance phase reduction when assessed by CGA [2].
Our study demonstrates that patients with CD have walking
abnormalities similar (although not clinically evident) to the ones
seen in Parkinsonian gait [10]. In keeping with a subtle instability
along the antero-posterior axis, our patients were found to walk at
a slower pace, with shorter steps and spending a relatively higher
time on double limb support. These results are in agreement with a
previous study reporting a low self-balance conﬁdence in CD pa-
tients, who were also found to have a reduced preferred walking
speed [11].
The lack of detrimental effect of forced head deviation in HC as
well as the lack of gait pattern change after BoNT treatment suggest
that the underlying mechanism of CD abnormal gait might not be
associated with the postural alterations caused by head and neck
deviation as they are well controlled by BoNT injections [12].
Therefore, it is reasonable to consider that basal ganglia dysfunc-
tion originating focal dystonia may contribute the observed
walking pathophysiology of CD patients.
Hypokinetic gait has been reported after pallidal DBS in a
number of operated patients with focal dystonia, including CD [3].
There are few interpretations of this effect of DBS, though some
authors suggest that globus pallidus internus stimulation may
interfere with basal ganglia control of automatic gait. Our evidence
of a slow gait even in unoperated CD patients may also support the
role of a basal ganglia dysfunction in walking abnormalities and
further suggest that gait disorder may be an endophenotipic
feature of idiopathic CD, possibly revealed by DBS.patients display subclinical gait changes, Parkinsonism and Related
Table 1
Demographic, clinical data and gait parameters of patients with cervical dystonia (CD), healthy controls (HC) and HC with turned head (HCht).
CD (n ¼ 13) HC (n ¼ 19) HCht (n ¼ 12) p value
(CD vs HC)
p value
(CD vs HCht)
p value
(HC vs HCht)
Demographic & clinical data
Age (y) 59.1 ± 10.9 55.5 ± 5.7 56.58 ± 6.13 ns ns ns
Sex (m/f) 6/7 12/7 9/4 ns ns ns
Disease duration 7.7 ± 10.1 na na
BoNT treatment duration 3.4 ± 2.9 na na
BoNT mean dose (U.I.)a 400 ± 100 na na
TWSTRS 16.15 ± 4.4 na na
Spatiotemporal parameters
Cadence (steps/min) 96.36 ± 3.25 104.35 ± 3.59 105.00 ± 2.54 ns 0.004 ns
Step length (m) 0.52 ± 0.02 0.66 ± 0.03 0.67 ± 0.03 ns 0.003 ns
Step asymmetry 0.98 ± 0.03 1.03 ± 0.01 1.02 ± 0.01 ns ns ns
Step width (%) 0.18 ± 0.01 0.15 ± 0.05 0.12 ± 0.02 ns ns ns
Stride time (s) 1.25 ± 0.04 1.15 ± 0.03 1.15 ± 0.03 ns ns ns
Stance time (s) 0.79 ± 0.03 0.72 ± 0.04 0.68 ± 0.05 ns ns ns
Swing time (s) 0.46 ± 0.01 0.46 ± 0.01 0.44 ± 0.01 ns ns ns
Double support time (s) 0.15 ± 0.01 0.12 ± 0.01 0.11 ± 0.01 ns ns ns
Stance time (%) 63.05 ± 1.48 60.52 ± 0.85 59.53 ± 0.63 ns ns ns
Swing time (%) 36.71 ± 0.50 39.47 ± 0.86 39.61 ± 0.53 0.001 0.001 ns
Double support time (%) 12.75 ± 1.02 11.35 ± 0.65 10.30 ± 0.59 ns ns ns
Stride length e CV 4.47 ± 0.61 2.39 ± 0.17 2.36 ± 0.51 ns ns ns
Swing time e CV 4.29 ± 1.48 1.85 ± 1.01 2.29 ± 2.71 0.001 ns ns
Stride time e CV 4.34 ± 1.65 2.24 ± 1.51 2.18 ± 0.66 0.011 0.001 ns
Velocity 0.82 ± 0.18 1.15 ± 0.22 1.20 ± 0.17 0.002 <0.001 ns
Stride length 1.09 ± 0.07 1.33 ± 0.13 1.35 ± 0.08 <0.001 <0.001 ns
Stability index 1.77 ± 0.93 4.31 ± 1.16 4.08 ± 1.21 <0.001 <0.001 ns
Demographic and clinical data are reported as mean ± SD (standard deviation); Spatiotemporal parameters are reported as median±SE (standard error); Mann-Whitney test
for comparisons group CD vs group HC and group CD vs group HCth, Wilcoxon-test for comparison group HC vs group HCth.
BoNT: botulinum toxin; TWSTRS: TorontoWestern spasmodic torticollis rating scale; na¼ not applicable; ns¼ not signiﬁcant; CV¼ coefﬁcient of variation; m¼male; f¼ fem.
Signiﬁcant values are reported in bold.
a Abobotulinumtoxin (Dysport™).
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lated idiopathic CD might present subtle, sub-clinical and endo-
phenotypical walking abnormalities consistent with a hypokinetic
gait. The major limitation of our study is the small sample size and
the fact that second condition was always performed after BoNT
(with patients more comfortable with the experimental set up). A
similar limitation applies to HCht as they all repeated theFig. 1. Gait parameters in patients with cervical dystonia (CD), healthy controls (HC)
and HC with turned head (HCht).
Figure Legend: p values for groups comparison with Kruskal-Wallis test: velocity
(p < 0.001); stride length (p < 0.001); stride time CV (p ¼ 0.002); swing time CV
(p ¼ 0.009); stability index (p < 0.001). Columns and bars show median
values þ standard error.
Please cite this article in press as: M. Esposito, et al., Cervical dystonia
Disorders (2017), http://dx.doi.org/10.1016/j.parkreldis.2017.07.005assessment after the ﬁrst evaluation with straight head position,
thus explaining the subtle improvement of their gait parameter
(practice effect). This result may further rule out the contribution of
postural alterations on gait parameters. Furthermore another lim-
itation of our study is that we cannot rule out a possible detri-
mental effect on gait resulting from prolonged BoNT treatment.
Future studies with larger samples are needed to conﬁrm our
ﬁndings in patients who have never received BoNT injections and
comparing DBS patients (under different stimulation conditions)
with unoperated CD patients. Finally, enrolling patients with other
types of dystonia would also be of interest. Overall, this and future
studies will certainly help understanding the pathophysiology of
basal ganglia control of gait.Funding for the study
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